Skip to main content

Meet Vaughn

Vaughn was diagnosed with mild hemophilia A at 18 months old. Growing up, his energetic and curious personality was a challenge because hemophilia limited his activities and left him feeling like he was “bubble-wrapped”. Hemophilia treatment was different when Vaughn was young and his treatments often took 8 hours a day at the hospital. As a teenager, he contracted HIV from contaminated products and was told he had less than 2 years to live. Although initially shaken by this news, Vaughn is not one to quit and now has his conditions under control. As an adult, Vaughn is passionate about staying fit through diet and exercise as well as sharing his story with the world. He also values a treatment that he can take with him as he lives his life.

Please see full Prescribing Information.
Individual results may vary.

USA17BIO02968
USA17BIO02968
Play
Pause
Skip
Volume
Chapters
Transcript
References
Subtitles
Fullscreen

Meet Vaughn

Chapters
Transcript
References

Vaughn was diagnosed with mild hemophilia A at 18 months old. Growing up, his energetic and curious personality was a challenge because hemophilia limited his activities and left him feeling like he was “bubble-wrapped”. Hemophilia treatment was different when Vaughn was young and his treatments often took 8 hours a day at the hospital. As a teenager, he contracted HIV from contaminated products and was told he had less than 2 years to live. Although initially shaken by this news, Vaughn is not one to quit and now has his conditions under control. As an adult, Vaughn is passionate about staying fit through diet and exercise as well as sharing his story with the world. He also values a treatment that he can take with him as he lives his life.

Please see full Prescribing Information.
Individual results may vary.

Return to overview

Transcripts

Return to overview

References


Selected Important Safety Information

You should not use Novoeight® if you are allergic to factor VIII or any of the other ingredients of Novoeight® or if you are allergic to hamster proteins.

Call your healthcare provider right away and stop treatment if you get any of the following signs of an allergic reaction: rashes or hives, difficulty breathing or swallowing, tightness of the chest, swelling of the lips and tongue, light-headedness, dizziness or loss of consciousness, pale and cold skin, fast heartbeat, or red or swollen face or hands.

Indications and Usage

Novoeight® (Antihemophilic Factor [Recombinant]) is an injectable medicine used to control and prevent bleeding in people with hemophilia A. Your healthcare provider may give you Novoeight® when you have surgery.

Novoeight® is not used to treat von Willebrand Disease.

Important Safety Information

You should not use Novoeight® if you are allergic to factor VIII or any of the other ingredients of Novoeight® or if you are allergic to hamster proteins.

Call your healthcare provider right away and stop treatment if you get any of the following signs of an allergic reaction: rashes or hives, difficulty breathing or swallowing, tightness of the chest, swelling of the lips and tongue, light-headedness, dizziness or loss of consciousness, pale and cold skin, fast heartbeat, or red or swollen face or hands.

Before taking Novoeight®, you should tell your healthcare provider if you have or have had any medical conditions, take any medicines (including non-prescription medicines and dietary supplements), are nursing, pregnant or planning to become pregnant, or have been told that you have inhibitors to factor VIII.

Your body can make antibodies called “inhibitors” against Novoeight®, which may stop Novoeight® from working properly. Call your healthcare provider right away if your bleeding does not stop after taking Novoeight®.

Common side effects of Novoeight® include swelling or itching at the location of injection, changes in liver tests, and fever.

Please click here for Prescribing Information.

Novoeight® is a prescription medication.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800- FDA-1088.